Avoiding malaria on holiday: evidence on how to reduce your infection risk

In this blog for people taking tropical holidays Robert Walton, a general practitioner, brings you up to date with the latest research on malaria prevention and gives practical tips for reducing your risk of infection. 

About 1,500 people return to the UK with malaria each year, most from visiting relatives or taking a well-earned holiday. It’s a very unpleasant and debilitating illness with a high death rate if access to medical care is limited.  Although prompt treatment is remarkably effective, delay in seeking help and making the diagnosis mean that around seven people still die from malaria annually in the UK.

If you are headed for a fancy hotel in a big city then your risk of catching malaria is pretty low but many people will travel to rural areas on safari or for sightseeing where rates of malaria transmission are high.

Prevention is better than cure and there is a wealth of Cochrane evidence about how to reduce the risk of infection.  Although most studies involve people living in countries where malaria is a common problem, their findings seem likely still to be relevant to visitors from abroad.

So how can I avoid catching malaria?

Repellents?

A mainstay of travel advice in the past has been the use of mosquito repellents and whilst using these chemicals still seems prudent there is no hard evidence of benefit.  Nor is there evidence to support use of mosquito coils and the mosquitos just laugh at electronic repellents!

Woman using anti mosquito spray outdoors at hiking trip

Better evidence is needed on whether mosquito repellants are effective in preventing malaria.

Bed nets

The hardest evidence on how to avoid malaria comes from studies on bed nets.  Mosquitos carrying malaria bite at night and nets over the bed have a long history of use for preventing transmission of malaria.  A stepwise improvement in the benefit arising from using bed nets came with the introduction of nets impregnated with insecticide.  Pyrethrins were the first chemicals used and probably reduce childhood deaths from all causes by one third when compared to untreated nets.

But a problem that has dogged malaria prevention for decades has been the development of resistance both in the malaria parasite and in the mosquitos that spread the infection. So we often use two drugs in combination when we are aiming to kill the malaria parasite, reasoning that resistance is unlikely to develop simultaneously to both drugs.  Now the same principle has been applied to strategies aimed at killing the mosquito.

Two in the bed (are two insecticides better than one?)

One would expect that nets impregnated with two insecticides that work in different ways would be more effective and perhaps work for a longer period of time than those which only used one.

Mosquito net hammocks

Nets have a long history of use for malaria prevention

But scientific evidence often flies in the face of logic! A Cochrane review of 15 trials found only one that showed malaria prevalence was reduced by the dual impregnated nets although mosquito populations and biting rates were reduced. There was also concern over whether the effects would be preserved after repeated washes.

Also somewhat disappointingly, it is uncertain whether spraying the bedroom at night with a non-pyrethrin insecticide in addition to using impregnated bed nets diminishes your chances of catching malaria. Perhaps the effect of the pyrethrin impregnated nets is so great that it is difficult to improve on it however logical those improvements might seem.  A sensible strategy for public health might then be simply to find better ways of encouraging people to use them.

Where does that leave the occasional traveller?

Insecticide treated bed nets remain the mainstay of malaria prevention.  Travellers will be wise to ensure that the places in which they stay are suitably equipped or to carry their own nets.

Taking preventive medication is also probably effective in preventing malaria infection – there is a range of different drugs with not much to choose between them in terms of effectiveness.  The balance of side effects probably favours atovaquone-proguanil or doxycycline over mefloquine.

Anecdotal non-Cochrane evidence from talking to people living in malarious areas suggests that another benefit of insecticide treated nets is that they keep down the bed bugs! Now what was the address of that fancy hotel?

Join in the conversation on Twitter with @rtwalton123 @CochraneUK or leave a comment on the blog.

References may be found here.

 


Robert Walton

About Robert Walton

view all posts

Robert Walton is a Cochrane UK Senior Fellow in General Practice. Robert qualified in medicine in London in 1983, having taken an intercalated degree in human pharmacology and immunology. He trained at St Georges Hospital, London and became a member of the Royal College of Physicians in 1986. His work applying computerised decision support to prescribing drugs in the Department of Public Health and Primary care in Oxford led to a doctoral thesis in 1998. Robert was elected a Fellow of the Royal College of General Practitioners in 1999 and the RoyalCollege of Physicians in 2001. He became a Senior Investigator in the National Institute for Health Research (NIHR) in 2016. Robert is Clinical Professor of Primary Medical Care at Queen Mary and joint lead of the NIHR Research Design Service east London team, his research interests are in primary care, genetics, clinical trials and personalised medicine. Robert leads a five-year NIHR funded programme developing a novel training intervention to promote smoking cessation in pharmacies in east London which involves a substantive systematic review and meta analysis on behaviour change interventions in community pharmacies and will lead to a large scale cluster-randomised clinical trial. His research team is also developing a smartphone game to promote smoking cessation and researching a personalised/stratified medicine approach to tobacco dependence using computerised decision support. He sits on the NIHR Programme Grants for Applied Research sub panel A and works as an evaluator for the European Union Horizon 2020 programme (Global Alliance for Chronic Diseases, New Therapies for Rare Diseases). He contributes to UK national guidance, serving on the National Institute for Health and Care Excellence (NICE) Outcome Indicator and Technology Appraisals Committees. He has worked as a general practitioner in Oxford since 1988.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

UA-49496932-1